US2003187048A1PendingUtilityA1

Method for inhibiting skin lesion formation using histamine as the active ingredient

57
Priority: Jun 14, 1991Filed: Sep 24, 2002Published: Oct 2, 2003
Est. expiryJun 14, 2011(expired)· nominal 20-yr term from priority
Inventors:Bruce A. JackB. Thomas White
A61K 31/417A61K 47/32A61K 31/675Y10S424/13A61K 9/0014
57
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

A pharmaceutical composition of water, water soluble vinyl polymer gel, amine alcohol dispersant and IEP is used topically to treat herpes labialis and aphthous stomatitis lesions, and also to treat herpes genitalis, chicken pox, allergic conjunctivitis, giant papillary conjunctivitis, stomatitis secondary to chemotherapy, thermal burn, sunburn, and decubitus ulcers and shingles.

Claims

exact text as granted — not AI-modified
What is claimed is:  
     
         1 . A method of preventing skin lesion formation comprising topically applying a composition comprising an effective dose of histamine.

Join the waitlist — get patent alerts

Track US2003187048A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.